Valuation : Drugs Made In America Acquisition II Corp.

Market Cap 647M 558M 525M 478M 899M 61.36B 904M 6.2B 2.41B 31.21B 2.43B 2.37B 103B P/E 2024 *
-
P/E 2025 65.5x
Enterprise Value 647M 558M 525M 478M 899M 61.36B 904M 6.2B 2.41B 31.21B 2.43B 2.37B 103B EV / Sales 2024 *
-
EV / Sales 2025 -
Free-Float
84.79%
Yield 2024 *
-
Yield 2025 -
1 day+0.05%
1 week+0.05%
Current month+0.05%
1 month+0.45%
3 months+0.94%
6 months+1.75%
Current year+2.58%
1 week 10.12
Extreme 10.1196
10.16
1 month 10.11
Extreme 10.11
10.21
Current year 9.88
Extreme 9.88
10.21
1 year 9.86
Extreme 9.86
10.21
3 years 9.86
Extreme 9.86
10.21
5 years 9.86
Extreme 9.86
10.21
10 years 9.86
Extreme 9.86
10.21
Date Insider Type Main position Quantity % Market Cap. Importance
9/26/25 Others

Director

100,000 -
9/26/25 Others

Chief Financial Officer

100,000 -
9/26/25 Others

Director

100,000 -
Change 5-day change 1-year change 3-year change Capi.($)
+0.05%+0.05% - - 647M
-2.43%-7.38% - - 745M
0.00%-0.39% - - 600M
-0.46%+0.09% - - 600M
+0.19%+0.05%+2.47% - 593M
-6.60%-9.73%+232.92%-80.92% 581M
-1.03%0.00% - - 577M
+0.76%+0.67% - - 508M
0.00%+0.05% - - 507M
Average -1.10%-0.82%+117.69%-80.92% 595.27M
Weighted average by Cap. -1.15%-0.96%+116.59%-80.92%

Financials

2024 2025
Net sales - -
Net income -455K -393K -369K -336K -633K -43.2M -636K -4.37M -1.7M -21.97M -1.71M -1.67M -72.86M 4.19M 3.61M 3.4M 3.1M 5.82M 397M 5.85M 40.16M 15.63M 202M 15.72M 15.38M 670M
Net Debt 233K 201K 189K 172K 324K 22.12M 326K 2.24M 870K 11.25M 875K 856K 37.31M -223 -192.36 -180.94 -164.84 -309.99 -21.16K -311.66 -2.14K -832.59 -10.77K -837.25 -819.1 -35.7K
Logo Drugs Made In America Acquisition II Corp.
Drugs Made In America Acquisition II Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. While the Company may pursue a business combination target in any business, industry or geographical location, it intends to focus its search for businesses in the pharmaceutical industry. The Company has neither engaged in any operations nor generated any revenue to date.
Employees
-
Date Price Change Volume
26-09-01 US$10.16 +0.05% 123,045
26-08-31 US$10.15 +0.10% 62,596
26-08-28 US$10.14 0.00% 317
26-08-27 US$10.14 +0.20% 207,490
26-08-26 US$10.12 -0.30% 288,736
  1. Stock Market
  2. Stocks
  3. DMII Stock